1NA8 image
Entry Detail
PDB ID:
1NA8
Title:
Crystal structure of ADP-ribosylation factor binding protein GGA1
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2002-11-27
Release Date:
2003-07-29
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.27
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ADP-ribosylation factor binding protein GGA1
Chain IDs:A, B
Chain Length:154
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Binding partners for the COOH-terminal appendage domains of the GGAs and gamma-adaptin
Mol.Cell.Biol. 14 2385 23898 (2003)
PMID: 12808037 DOI: 10.1091/mbc.E02-11-0735

Abstact

The adaptor appendage domains are believed to act as binding platforms for coated vesicle accessory proteins. Using glutathione S-transferase pulldowns from pig brain cytosol, we find three proteins that can bind to the appendage domains of both the AP-1 gamma subunit and the GGAs: gamma-synergin and two novel proteins, p56 and p200. p56 elicited better antibodies than p200 and was generally more tractable. Although p56 and gamma-synergin bind to both GGA and gamma appendages in vitro, immunofluorescence labeling of nocodazole-treated cells shows that p56 colocalizes with GGAs on TGN46-positive membranes, whereas gamma-synergin colocalizes with AP-1 primarily on a different membrane compartment. Furthermore, in AP-1-deficient cells, p56 remains membrane-associated whereas gamma-synergin becomes cytosolic. Thus, p56 and gamma-synergin show very strong preferences for GGAs and AP-1, respectively, in vivo. However, the GGA and gamma appendages share the same fold as determined by x-ray crystallography, and mutagenesis reveals that the same amino acids contribute to their binding sites. By overexpressing wild-type GGA and gamma appendage domains in cells, we can drive p56 and gamma-synergin, respectively, into the cytosol, suggesting a possible mechanism for selectively disrupting the two pathways.

Legend

Protein

Chemical

Disease

Primary Citation of related structures